Assenagon Asset Management
PACB icon

Assenagon Asset Management’s Pacific Biosciences PACB Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-213,091
Closed -$390K 1272
2024
Q4
$390K Sell
213,091
-68,796
-24% -$126K ﹤0.01% 1204
2024
Q3
$479K Sell
281,887
-1,013,416
-78% -$1.72M ﹤0.01% 1210
2024
Q2
$1.77M Buy
+1,295,303
New +$1.77M ﹤0.01% 923
2024
Q1
Sell
-3,041,624
Closed -$29.8M 1409
2023
Q4
$29.8M Buy
3,041,624
+2,909,439
+2,201% +$28.5M 0.08% 179
2023
Q3
$1.1M Buy
+132,185
New +$1.1M ﹤0.01% 989
2023
Q2
Sell
-11,292
Closed -$131K 1387
2023
Q1
$131K Sell
11,292
-238,838
-95% -$2.77M ﹤0.01% 1337
2022
Q4
$2.05M Sell
250,130
-545
-0.2% -$4.46K 0.01% 774
2022
Q3
$1.46M Hold
250,675
0.01% 790
2022
Q2
$1.11M Buy
+250,675
New +$1.11M ﹤0.01% 1023
2022
Q1
Sell
-48,822
Closed -$999K 1470
2021
Q4
$999K Buy
48,822
+16,281
+50% +$333K ﹤0.01% 995
2021
Q3
$831K Sell
32,541
-47,457
-59% -$1.21M ﹤0.01% 910
2021
Q2
$2.8M Sell
79,998
-543,073
-87% -$19M 0.01% 570
2021
Q1
$20.8M Sell
623,071
-12,997
-2% -$433K 0.08% 188
2020
Q4
$16.5M Sell
636,068
-234,203
-27% -$6.08M 0.07% 150
2020
Q3
$8.59M Sell
870,271
-118,913
-12% -$1.17M 0.05% 188
2020
Q2
$3.41M Sell
989,184
-542,166
-35% -$1.87M 0.02% 410
2020
Q1
$4.69M Buy
+1,531,350
New +$4.69M 0.04% 211
2019
Q4
Sell
-980,997
Closed -$5.06M 849
2019
Q3
$5.06M Buy
+980,997
New +$5.06M 0.03% 198
2019
Q1
Sell
-116,302
Closed -$861K 1021
2018
Q4
$861K Buy
+116,302
New +$861K 0.01% 651